Cases
Search
Statistics
Estimate
SEARCH
Show Filters
Decision Date
October, 2018
(1)
August, 2018
(1)
March, 2018
(2)
January, 2018
(1)
Decision
Transfer
(4)
Complaint denied
(1)
Complainant
iNova Pharmaceuticals (Singapore) Pte. Limited
(1)
Worldwide IP Management Limited
(1)
ISISPHARMA France SAS
(1)
ISIS PHARMA GmbH
(1)
Bayer AG
(1)
Avon Products, Inc.
(1)
Respondent
Registration Private, Domains By Proxy, LLC / Zen Supplements Ltd
(1)
Registration Private, Domains By Proxy, LLC / Mark Miller
(1)
Pro Spedition
(1)
Nikolay Petkov, Kin Eood
(1)
Jenika Mukoro, Heirs Holdings
(1)
Daniel Constantinescu
(1)
Panelist
Luca Barbero
(5)
Ike Ehiribe
(1)
Clive N.A. Trotman
(1)
Complainant Country
United States
(1)
Singapore
(1)
Poland
(1)
Germany
(1)
France
(1)
Complainant Representative
CSC Digital Brand Services
(1)
Biuro Rachunkowe Warszawa (BRW)
(1)
BPM Legal
(1)
Adams & Adams Attorneys
(1)
Respondent Country
United States
(1)
Romania
(1)
Niger
(1)
Germany
(1)
Bulgaria
(1)
Respondent Representative
Technology Advisors LLP
(1)
Respondent Reply
Yes
(2)
No
(3)
RDNH Status
No
(4)
Case Language
English
(5)
Case Particular
D
(5)
Number Of Domains
1
(3)
3
(2)
Domain Extension
com
(4)
org
(1)
Domain Extension Type
gTLD
(5)
Domain Length
13
(2)
14
(5)
15
(1)
Includes Hyphen
Yes
(1)
No
(4)
Includes Number
No
(5)
Includes Letter
Yes
(5)
Domain Registrar
GoDaddy.com, LLC
(3)
eNom, Inc.
(1)
Hosting Concepts B.V. d/b/a Openprovider
(1)
5
cases found.
Case Language: English
Decision Date: 2018
Includes Number: No
Domain Length: 14
Panelist: Luca Barbero
Reset Search
duromineonline.com
Transfer
WIPO D2018-1836
(Decision Date: Oct. 2, 2018)
avonhealthcare.com
Complaint denied
WIPO D2018-1195
(Decision Date: Aug. 21, 2018)
buy-isispharma.com, isispharma-uk.com, isispharma-usa.com
Transfer
WIPO D2018-0095
(Decision Date: March 15, 2018)
bayermarijuana.org
Transfer
WIPO D2017-2540
(Decision Date: March 19, 2018)
perleblueshop.com, perlebleucream.com, perlebleuecreme.com
Transfer
WIPO D2017-2403
(Decision Date: Jan. 30, 2018)
Stay updated! Get new cases and decisions by daily email.
leave this field blank to prove your humanity
Subscribe
Scroll